Mirae Asset Global ETFs Holdings
CATX icon

Mirae Asset Global ETFs Holdings’s Perspective Therapeutics CATX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
60,592
+25,751
+74% +$97.3K ﹤0.01% 2464
2026
Q1 		$143K Buy
34,841
+7,176
+26% +$30.3K ﹤0.01% 2517
2025
Q4 		$76.1K Sell
27,665
-321
-1% -$916 ﹤0.01% 2792
2025
Q3 		$96K Sell
27,986
-4,623
-14% -$16.9K ﹤0.01% 2679
2025
Q2 		$112K Buy
32,609
+260
+0.8% +$686 ﹤0.01% 2552
2025
Q1 		$68.9K Buy
32,349
+1,410
+5% +$4.23K ﹤0.01% 2769
2024
Q4 		$98.7K Sell
30,939
-2,606
-8% -$21.3K ﹤0.01% 2705
2024
Q3 		$445K Buy
+33,545
New +$446K ﹤0.01% 1974

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Mirae Asset Global ETFs Holdings's CATX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Perspective Therapeutics (CATX) stake by 74% in Q2 2026, buying an estimated $97.3K and bringing the position to 60,592 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Mirae Asset Global ETFs Holdings first reported a position in CATX in Q3 2024 and has held it in 8 quarters since. The position peaked at $445K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 60,592 shares of Perspective Therapeutics worth $208K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 25,751 Perspective Therapeutics shares in Q2 2026, an estimated $97.3K.
  • Perspective Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2464 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Perspective Therapeutics position peaked at $445K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.